Novel Tricyclic Heteroaryl Compounds as IRAK4 Inhibitors for Treating Cancer, Autoimmune and Inflammatory Diseases

  • ACS Med Chem Lett. 2022 Feb 28;13(3):336-337. doi: 10.1021/acsmedchemlett.2c00060.
Ram W Sabnis  1
Affiliations
  • 1. Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.
PMID: 35300088 DOI: 10.1021/acsmedchemlett.2c00060
Products